Clinical Trial Update: Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 trial update for BPZE1 intranasal pertussis vaccine (Prime + Boost) in healthy adults; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis
• Whooping Cough

Drugs mentioned

• BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator) (BPZE1 intranasal pertussis vaccine)

Snippet

Sponsor: ILiAD Biotechnologies | Conditions: Pertussis, Whooping Cough | Phase 2 | Status: COMPLETED | Results posted: 2023-06-27